Preparation and
Characterization of Nanoliposomal Beta-Cryptoxanthin and
its Effect on Proliferation and Apoptosis in Human
Leukemia Cell Line K562
Amir Gharib1*,
Zohreh Faezizadeh1 and Masoud Godarzee2
1Department of Laboratory
Sciences, Borujerd Branch, Islamic Azad University,
Borujerd, Iran, 2Department of Biology,
Borujerd Branch, Islamic Azad University, Borujerd, Iran
*For correspondence:
Email:
amirgharib@gmail.com; Tel:
+986623500201; Fax: +986624453013
Received: 22 October 2014
Revised accepted: 16
January 2015
Tropical Journal of Pharmaceutical Research,
February 2015;
14(2): 187-194
http://dx.doi.org/10.4314/tjpr.v14i2.1
Abstract
Purpose: To prepare beta-cryptoxanthin-loaded
nanoliposomes and evaluate their anti-proliferative
activity in leukemia K562 cell line, compared to free
beta-cryptoxanthin.
Methods: Beta-cryptoxanthin-loaded
nanoliposomes were prepared by extrusion method.
Morphological characterization of the nanoliposomes was
performed by cryo-transmission electron microscopy (cryo-TEM).
The anti-proliferation effect of beta-cryptoxanthin (BC)
in free and liposomal forms on K562 cell line was
studied using 3-(4, 5-dimethylthiazol-2-yl)-2,
5-diphenyl tetrazolium bromide assay. Apoptotic
activity, following treatment with beta-cryptoxanthin in
the free and liposomal forms, was detected using flow
cytometry.
Results: Entrapment efficiency of
beta-cryptoxanthin was 86.3 % ± 1.0. Cryo-TEM analysis
revealed that the nanoliposomes have spherical shapes.
In all conditions, beta-cryptoxanthin-loaded
nanoliposomes exhibited greater anti-proliferative
activity than than the free beta-cryptoxanthin (p <
0.001). Furthermore, in the presence of beta-cryptoxanthin-loaded
nanoliposomes, the proportion of apoptotic cells was
higher for free beta-cryptoxanthin (p < 0.001).
Conclusion: The data obtained indicate
that beta-cryptoxanthin, especially in the liposomal
form, inhibits the growth of K562 cells and may
therefore provide a basis for the development of
leukemia therapies.
Keywords: Beta-cryptoxanthin,
Nanoliposome, Anti-proliferative, Apoptosis, Flow
cytometry, Leukemia